Latest On Eton Pharmaceuticals, Inc (ETON):
About Eton Pharmaceuticals, Inc (ETON):
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300 and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension. Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois.
General
- Name Eton Pharmaceuticals, Inc
- Symbol ETON
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 17
- Fiscal Year EndDecember
- IPO Date2018-11-13
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.etonpharma.com
Valuation
- Price/Sales (Trailing 12 Mt.) 4320.52
- Price/Book (Most Recent Quarter) 12.5
- Enterprise Value Revenue 4656.31
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.24
- Next Year EPS Estimate $0.30
- Next Quarter EPS Estimate -$0.24
- Operating Margin -69515%
- Return on Assets -78%
- Return on Equity -213%
- Revenue 39000
- Earnings Per Share -$3.07
- Revenue Per Share $0
- Gross Profit -247000
- Quarterly Earnings Growth -82.4%
Highlights
- Market Capitalization 200.63 million
- EBITDA -15345000
- PE Ratio -17.77
- Analyst Target Price $13.5
- Book Value Per Share $0.64
Share Statistics
- Shares Outstanding 24.41 million
- Shares Float 13.73 million
- % Held by Insiders 2803%
- % Held by Institutions 29.14%
- Shares Short 788868
- Shares Short Prior Month 807494
- Short Ratio 4.72
- Short % of Float 5%
- Short % of Shares Outstanding 3%
Technicals
- Beta 1.23
- 52 Week High $10.3
- 52 Week Low $2.75
- 50 Day Moving Average 8.8
- 200 Day Moving Average 8.15
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Eton Pharmaceuticals, Inc (ETON) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Eton Pharmaceuticals, Inc (ETON) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2020-12-31 | $N/A | -$0.32 | -$0.26 | -23.08% |
2020-09-30 | 2020-11-12 | $-161000 | -$0.31 | -$0.25 | -22.38% |
2020-06-30 | 2020-08-12 | $N/A | -$0.23 | -$0.26 | 11.54% |
2020-03-31 | 2020-05-14 | $99000 | -$0.50 | -$0.22 | -123.91% |
2019-12-31 | 2020-03-05 | $459000 | -$0.15 | -$0.26 | 43.03% |
2019-09-30 | 2019-11-14 | $N/A | -$0.28 | -$0.25 | -13.5% |
2019-06-30 | 2019-08-06 | $N/A | -$0.18 | -$0.28 | 34.55% |
2019-03-31 | 2019-05-07 | $500000 | -$0.42 | ||
2018-12-31 | 2019-03-25 | $N/A | -$2.24 | ||
2018-09-30 | 2018-12-20 | $N/A | -$2.24 |
Eton Pharmaceuticals, Inc (ETON) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Eton Pharmaceuticals, Inc (ETON) Chart:
Eton Pharmaceuticals, Inc (ETON) News:
Below you will find a list of latest news for Eton Pharmaceuticals, Inc (ETON) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Eton Pharmaceuticals, Inc (ETON) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2025-04-17 | 2.5 | 0 | CALL | 0 | 0 | 521.06 | TRUE | 0 | 0 |
2025-04-17 | 5 | 0 | CALL | 0 | 0 | 309.48 | TRUE | 0 | 0 |
2025-04-17 | 7.5 | 0 | CALL | 0 | 0 | 406.28 | TRUE | 0 | 0 |
2025-04-17 | 10 | 0 | CALL | 0 | 0 | 136.24 | TRUE | 0 | 0 |
2025-04-17 | 12.5 | 0 | CALL | 0 | 0 | 88.76 | TRUE | 0 | 0 |
2025-04-17 | 15 | 0 | CALL | 0 | 0 | 147.26 | FALSE | 0 | 0 |
2025-04-17 | 17.5 | 0 | CALL | 0 | 0 | 189.23 | FALSE | 0 | 0 |
2025-04-17 | 20 | 0 | CALL | 0 | 0 | 191.11 | FALSE | 0 | 0 |
2025-04-17 | 22.5 | 0 | CALL | 0 | 0 | 271.74 | FALSE | 0 | 0 |
2025-04-17 | 25 | 0.05 | CALL | 0 | 10 | 160.8 | FALSE | 0 | 0 |
2025-04-17 | 30 | 0 | CALL | 0 | 0 | 342.1 | FALSE | 0 | 0 |
2025-04-17 | 2.5 | 0 | PUT | 0 | 0 | 920.27 | FALSE | 0 | 0 |
2025-04-17 | 5 | 0 | PUT | 0 | 0 | 532.01 | FALSE | 0 | 0 |
2025-04-17 | 7.5 | 0 | PUT | 0 | 0 | 347.8 | FALSE | 0 | 0 |
2025-04-17 | 10 | 0 | PUT | 0 | 0 | 183.41 | FALSE | 0 | 0 |
2025-04-17 | 12.5 | 0.65 | PUT | 0 | 310 | 152.39 | FALSE | 0 | 0 |
2025-04-17 | 15 | 0 | PUT | 0 | 0 | 102.18 | TRUE | 0 | 0 |
2025-04-17 | 17.5 | 0 | PUT | 0 | 0 | 217.03 | TRUE | 0 | 0 |
2025-04-17 | 20 | 0 | PUT | 0 | 0 | 128.16 | TRUE | 0 | 0 |
2025-04-17 | 22.5 | 0 | PUT | 0 | 0 | 308.58 | TRUE | 0 | 0 |
2025-04-17 | 25 | 0 | PUT | 0 | 0 | 175.13 | TRUE | 0 | 0 |
2025-04-17 | 30 | 0 | PUT | 0 | 0 | 173.08 | TRUE | 0 | 0 |
2025-05-16 | 2.5 | 11.9 | CALL | 0 | 23 | 361.01 | TRUE | 0 | 0 |
2025-05-16 | 5 | 5.25 | CALL | 0 | 3 | 178.53 | TRUE | 0 | 0 |
2025-05-16 | 7.5 | 9.42 | CALL | 0 | 53 | 125.82 | TRUE | 0 | 0 |
2025-05-16 | 10 | 7.9 | CALL | 0 | 27 | 92.15 | TRUE | 0 | 0 |
2025-05-16 | 12.5 | 4 | CALL | 0 | 46 | 89.35 | TRUE | 0 | 0 |
2025-05-16 | 15 | 2.6 | CALL | 0 | 124 | 94.57 | FALSE | 0 | 0 |
2025-05-16 | 17.5 | 0.9 | CALL | 1 | 483 | 115.42 | FALSE | 0.9 | 0 |
2025-05-16 | 20 | 2.5 | CALL | 0 | 11 | 117.88 | FALSE | 0 | 0 |
2025-05-16 | 22.5 | 1.1 | CALL | 0 | 6 | 171.95 | FALSE | 0 | 0 |
2025-05-16 | 25 | 0.7 | CALL | 0 | 11 | 188.89 | FALSE | 0 | 0 |
2025-05-16 | 30 | 0.25 | CALL | 0 | 1 | 216.39 | FALSE | 0 | 0 |
2025-05-16 | 35 | 0.2 | CALL | 0 | 1 | 238.22 | FALSE | 0 | 0 |
2025-05-16 | 2.5 | 0 | PUT | 0 | 0 | 580.3 | FALSE | 0 | 0 |
2025-05-16 | 5 | 0 | PUT | 0 | 0 | 335.65 | FALSE | 0 | 0 |
2025-05-16 | 7.5 | 0.15 | PUT | 0 | 3 | 222.1 | FALSE | 0 | 0 |
2025-05-16 | 10 | 0.85 | PUT | 0 | 13 | 123.71 | FALSE | 0 | 0 |
2025-05-16 | 12.5 | 1.9 | PUT | 0 | 20 | 83.06 | FALSE | 0 | 0 |
2025-05-16 | 15 | 1.65 | PUT | 0 | 1 | 111.86 | TRUE | 0 | 0 |
2025-05-16 | 17.5 | 0 | PUT | 0 | 0 | 80.6 | TRUE | 0 | 0 |
2025-05-16 | 20 | 5.9 | PUT | 0 | 9 | 100.35 | TRUE | 0 | 0 |
2025-05-16 | 22.5 | 0 | PUT | 0 | 0 | 208.48 | TRUE | 0 | 0 |
2025-05-16 | 25 | 12 | PUT | 0 | 2 | 220.89 | TRUE | 0 | 0 |
2025-05-16 | 30 | 0 | PUT | 0 | 0 | 256.34 | TRUE | 0 | 0 |
2025-05-16 | 35 | 0 | PUT | 0 | 0 | 280.07 | TRUE | 0 | 0 |
2025-08-15 | 2.5 | 0 | CALL | 0 | 0 | 208.22 | TRUE | 0 | 0 |
2025-08-15 | 5 | 13.3 | CALL | 0 | 122 | 242.63 | TRUE | 0 | 0 |
2025-08-15 | 7.5 | 10.15 | CALL | 0 | 5 | 76.88 | TRUE | 0 | 0 |
2025-08-15 | 10 | 0 | CALL | 0 | 0 | 72.95 | TRUE | 0 | 0 |
2025-08-15 | 12.5 | 3 | CALL | 0 | 5 | 72.64 | TRUE | 0 | 0 |
2025-08-15 | 15 | 2.7 | CALL | 0 | 12 | 69.86 | FALSE | 0 | 0 |
2025-08-15 | 17.5 | 1.2 | CALL | 0 | 38 | 89.82 | FALSE | 0 | 0 |
2025-08-15 | 20 | 3.21 | CALL | 0 | 25 | 95.87 | FALSE | 0 | 0 |
2025-08-15 | 22.5 | 2.05 | CALL | 0 | 1 | 94.45 | FALSE | 0 | 0 |
2025-08-15 | 25 | 0.75 | CALL | 0 | 32 | 95.15 | FALSE | 0 | 0 |
2025-08-15 | 30 | 0.5 | CALL | 0 | 32 | 102.35 | FALSE | 0 | 0 |
2025-08-15 | 35 | 0.2 | CALL | 0 | 2 | 138.11 | FALSE | 0 | 0 |
2025-08-15 | 2.5 | 0 | PUT | 0 | 0 | 343.38 | FALSE | 0 | 0 |
2025-08-15 | 5 | 0 | PUT | 0 | 0 | 311.15 | FALSE | 0 | 0 |
2025-08-15 | 7.5 | 0.22 | PUT | 0 | 3 | 105.12 | FALSE | 0 | 0 |
2025-08-15 | 10 | 0 | PUT | 0 | 0 | 141.01 | FALSE | 0 | 0 |
2025-08-15 | 12.5 | 1.75 | PUT | 0 | 27 | 63.83 | FALSE | 0 | 0 |
2025-08-15 | 15 | 2.5 | PUT | 0 | 3 | 77.89 | TRUE | 0 | 0 |
2025-08-15 | 17.5 | 3.6 | PUT | 0 | 1 | 68.09 | TRUE | 0 | 0 |
2025-08-15 | 20 | 0 | PUT | 0 | 0 | 81.29 | TRUE | 0 | 0 |
2025-08-15 | 22.5 | 0 | PUT | 0 | 0 | 70.06 | TRUE | 0 | 0 |
2025-08-15 | 25 | 0 | PUT | 0 | 0 | 79.63 | TRUE | 0 | 0 |
2025-08-15 | 30 | 0 | PUT | 0 | 0 | 153.65 | TRUE | 0 | 0 |
2025-08-15 | 35 | 0 | PUT | 0 | 0 | 100.11 | TRUE | 0 | 0 |
2025-11-21 | 2.5 | 0 | CALL | 0 | 0 | 313.34 | TRUE | 0 | 0 |
2025-11-21 | 5 | 0 | CALL | 0 | 0 | 64.1 | TRUE | 0 | 0 |
2025-11-21 | 7.5 | 0 | CALL | 0 | 0 | 67.2 | TRUE | 0 | 0 |
2025-11-21 | 10 | 0 | CALL | 0 | 0 | 81.67 | TRUE | 0 | 0 |
2025-11-21 | 12.5 | 0 | CALL | 0 | 0 | 75.95 | TRUE | 0 | 0 |
2025-11-21 | 15 | 0 | CALL | 0 | 0 | 90.15 | FALSE | 0 | 0 |
2025-11-21 | 17.5 | 0 | CALL | 0 | 0 | 77.45 | FALSE | 0 | 0 |
2025-11-21 | 20 | 0 | CALL | 0 | 0 | 71.86 | FALSE | 0 | 0 |
2025-11-21 | 22.5 | 0 | CALL | 0 | 0 | 74.35 | FALSE | 0 | 0 |
2025-11-21 | 25 | 0 | CALL | 0 | 0 | 78.34 | FALSE | 0 | 0 |
2025-11-21 | 30 | 0 | CALL | 0 | 0 | 85.74 | FALSE | 0 | 0 |
2025-11-21 | 2.5 | 0 | PUT | 0 | 0 | 268.16 | FALSE | 0 | 0 |
2025-11-21 | 5 | 0 | PUT | 0 | 0 | 244.01 | FALSE | 0 | 0 |
2025-11-21 | 7.5 | 0 | PUT | 0 | 0 | 91.1 | FALSE | 0 | 0 |
2025-11-21 | 10 | 0 | PUT | 0 | 0 | 74.49 | FALSE | 0 | 0 |
2025-11-21 | 12.5 | 0 | PUT | 0 | 0 | 75.4 | FALSE | 0 | 0 |
2025-11-21 | 15 | 0 | PUT | 0 | 0 | 90.08 | TRUE | 0 | 0 |
2025-11-21 | 17.5 | 0 | PUT | 0 | 0 | 76.37 | TRUE | 0 | 0 |
2025-11-21 | 20 | 0 | PUT | 0 | 0 | 72.44 | TRUE | 0 | 0 |
2025-11-21 | 22.5 | 0 | PUT | 0 | 0 | 70.77 | TRUE | 0 | 0 |
2025-11-21 | 25 | 0 | PUT | 0 | 0 | 77.47 | TRUE | 0 | 0 |
2025-11-21 | 30 | 0 | PUT | 0 | 0 | 124.88 | TRUE | 0 | 0 |
Latest ETON Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 5:36 PM EST | 2 | $2.885 |
Jun 13, 2022 5:47 PM EST | 4 | $2.885 |
Jun 13, 2022 6:38 PM EST | 13 | $2.9 |
Jun 13, 2022 7:24 PM EST | 100 | $2.9 |
Jun 13, 2022 7:25 PM EST | 100 | $2.86 |
Eton Pharmaceuticals, Inc (ETON) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220010937/0001493152-20-010937-index.htm |
2019-12-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1710340/000000000019016252/0000000000-19-016252-index.htm |
2020-05-05 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1710340/000000000020003885/0000000000-20-003885-index.htm |
2020-05-27 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1710340/000000000020004688/0000000000-20-004688-index.htm |
2020-08-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1710340/000000000020007104/0000000000-20-007104-index.htm |
2018-11-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1710340/000089914018000602/0000899140-18-000602-index.htm |
2018-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058316/0001209191-18-058316-index.htm |
2018-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058318/0001209191-18-058318-index.htm |
2018-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058320/0001209191-18-058320-index.htm |
2018-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058321/0001209191-18-058321-index.htm |
2018-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058324/0001209191-18-058324-index.htm |
2018-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058325/0001209191-18-058325-index.htm |
2018-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058821/0001209191-18-058821-index.htm |
2018-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058822/0001209191-18-058822-index.htm |
2018-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058824/0001209191-18-058824-index.htm |
2018-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058825/0001209191-18-058825-index.htm |
2018-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058826/0001209191-18-058826-index.htm |
2018-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058827/0001209191-18-058827-index.htm |
2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919119018103/0001209191-19-018103-index.htm |
2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919119018106/0001209191-19-018106-index.htm |
2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919119018109/0001209191-19-018109-index.htm |
2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919119018114/0001209191-19-018114-index.htm |
2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919119018118/0001209191-19-018118-index.htm |
2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919119018122/0001209191-19-018122-index.htm |
2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919119032054/0001209191-19-032054-index.htm |
2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919119045498/0001209191-19-045498-index.htm |
2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000120919119045738/0001209191-19-045738-index.htm |
2018-11-08 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1710340/000135445718000454/0001354457-18-000454-index.htm |
2017-06-28 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315217007275/0001493152-17-007275-index.htm |
2018-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315218015806/0001493152-18-015806-index.htm |
2018-11-23 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1710340/000149315218016669/0001493152-18-016669-index.htm |
2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315218017722/0001493152-18-017722-index.htm |
2018-12-20 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1710340/000149315218017724/0001493152-18-017724-index.htm |
2019-01-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219000907/0001493152-19-000907-index.htm |
2019-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219001663/0001493152-19-001663-index.htm |
2019-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1710340/000149315219001718/0001493152-19-001718-index.htm |
2019-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219002230/0001493152-19-002230-index.htm |
2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219003813/0001493152-19-003813-index.htm |
2019-03-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1710340/000149315219003817/0001493152-19-003817-index.htm |
2019-03-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1710340/000149315219004108/0001493152-19-004108-index.htm |
2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1710340/000149315219006004/0001493152-19-006004-index.htm |
2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1710340/000149315219006005/0001493152-19-006005-index.htm |
2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219006515/0001493152-19-006515-index.htm |
2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1710340/000149315219006526/0001493152-19-006526-index.htm |
2019-05-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1710340/000149315219008254/0001493152-19-008254-index.htm |
2019-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219009066/0001493152-19-009066-index.htm |
2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219009127/0001493152-19-009127-index.htm |
2019-07-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219010573/0001493152-19-010573-index.htm |
2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219011467/0001493152-19-011467-index.htm |
2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219011725/0001493152-19-011725-index.htm |
2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1710340/000149315219011727/0001493152-19-011727-index.htm |
2019-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219012932/0001493152-19-012932-index.htm |
2019-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219015787/0001493152-19-015787-index.htm |
2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219017479/0001493152-19-017479-index.htm |
2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1710340/000149315219017499/0001493152-19-017499-index.htm |
2019-12-02 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1710340/000149315219018638/0001493152-19-018638-index.htm |
2019-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219018669/0001493152-19-018669-index.htm |
2019-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315219019062/0001493152-19-019062-index.htm |
2019-12-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1710340/000149315219019077/0001493152-19-019077-index.htm |
2020-01-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220000810/0001493152-20-000810-index.htm |
2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1710340/000149315220001575/0001493152-20-001575-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1710340/000149315220002532/0001493152-20-002532-index.htm |
2020-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220002695/0001493152-20-002695-index.htm |
2020-03-05 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1710340/000149315220003451/0001493152-20-003451-index.htm |
2020-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220003486/0001493152-20-003486-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315220004052/0001493152-20-004052-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315220004053/0001493152-20-004053-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315220004056/0001493152-20-004056-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315220004058/0001493152-20-004058-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315220004059/0001493152-20-004059-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315220004062/0001493152-20-004062-index.htm |
2020-03-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220004113/0001493152-20-004113-index.htm |
2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220004191/0001493152-20-004191-index.htm |
2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220005035/0001493152-20-005035-index.htm |
2020-03-30 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1710340/000149315220005038/0001493152-20-005038-index.htm |
2020-04-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315220005927/0001493152-20-005927-index.htm |
2020-04-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1710340/000149315220005929/0001493152-20-005929-index.htm |
2020-04-08 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315220006039/0001493152-20-006039-index.htm |
2020-04-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1710340/000149315220006934/0001493152-20-006934-index.htm |
2020-04-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1710340/000149315220006939/0001493152-20-006939-index.htm |
2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220007595/0001493152-20-007595-index.htm |
2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220007843/0001493152-20-007843-index.htm |
2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220007957/0001493152-20-007957-index.htm |
2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220008752/0001493152-20-008752-index.htm |
2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1710340/000149315220008763/0001493152-20-008763-index.htm |
2020-05-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1710340/000149315220009223/0001493152-20-009223-index.htm |
2020-05-21 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1710340/000149315220009627/0001493152-20-009627-index.htm |
2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220010937/0001493152-20-010937-index.htm |
2020-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220014011/0001493152-20-014011-index.htm |
2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220014213/0001493152-20-014213-index.htm |
2020-07-31 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1710340/000149315220014330/0001493152-20-014330-index.htm |
2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220014335/0001493152-20-014335-index.htm |
2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220015198/0001493152-20-015198-index.htm |
2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220015303/0001493152-20-015303-index.htm |
2020-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1710340/000149315220015336/0001493152-20-015336-index.htm |
2020-08-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1710340/000149315220016594/0001493152-20-016594-index.htm |
2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220016975/0001493152-20-016975-index.htm |
2020-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220017873/0001493152-20-017873-index.htm |
2020-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220018322/0001493152-20-018322-index.htm |
2020-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220018576/0001493152-20-018576-index.htm |
2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019035/0001493152-20-019035-index.htm |
2020-10-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019121/0001493152-20-019121-index.htm |
2020-10-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019347/0001493152-20-019347-index.htm |
2020-10-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019406/0001493152-20-019406-index.htm |
2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019467/0001493152-20-019467-index.htm |
2020-10-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019503/0001493152-20-019503-index.htm |
2020-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019583/0001493152-20-019583-index.htm |
2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019587/0001493152-20-019587-index.htm |
2018-03-20 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1710340/000161577418002013/0001615774-18-002013-index.htm |
2018-06-28 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1710340/000161577418005879/0001615774-18-005879-index.htm |
2018-08-10 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1710340/000161577418007833/0001615774-18-007833-index.htm |
2018-09-25 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1710340/000161577418009956/0001615774-18-009956-index.htm |
2018-09-28 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1710340/000161577418010167/0001615774-18-010167-index.htm |
2018-10-18 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1710340/000161577418011027/0001615774-18-011027-index.htm |
2018-10-31 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1710340/000161577418011677/0001615774-18-011677-index.htm |
2018-11-05 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1710340/000161577418012090/0001615774-18-012090-index.htm |
2018-11-08 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1710340/000161577418012296/0001615774-18-012296-index.htm |
2018-11-13 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1710340/000161577418012575/0001615774-18-012575-index.htm |
2018-11-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1710340/000161577418013052/0001615774-18-013052-index.htm |
2018-11-20 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1710340/000161577418013060/0001615774-18-013060-index.htm |
2018-11-09 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1710340/999999999518002850/9999999995-18-002850-index.htm |
2019-12-16 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1710340/999999999519002824/9999999995-19-002824-index.htm |
2020-08-25 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1710340/999999999520002245/9999999995-20-002245-index.htm |
2018-11-09 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1710340/999999999718008960/9999999997-18-008960-index.htm |
Eton Pharmaceuticals, Inc (ETON) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eton Pharmaceuticals, Inc (ETON). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2803%Institutional Ownership: 2914%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-11-15 | MARK L BAUM | Director | Buy | 10,000.00 | 6.00 | 60,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058821/0001209191-18-058821-index.htm |
2018-11-15 | SEAN BRYNJELSEN | President & CEO | Buy | 10,000.00 | 6.00 | 60,000.00 | 1,010,000.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058826/0001209191-18-058826-index.htm |
2019-05-20 | SEAN BRYNJELSEN | President & CEO | Buy | 1,400.00 | 7.78 | 10,894.80 | 1,011,400.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919119032054/0001209191-19-032054-index.htm |
2019-05-21 | SEAN BRYNJELSEN | President & CEO | Buy | 8,600.00 | 7.96 | 68,431.06 | 1,020,000.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919119032054/0001209191-19-032054-index.htm |
2019-08-13 | SEAN BRYNJELSEN | President & CEO | Buy | 5,000.00 | 6.15 | 30,750.00 | 1,025,000.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919119045738/0001209191-19-045738-index.htm |
2020-10-16 | Opaleye Management Inc. | 10% Share Holder | Buy | 15,000.00 | 7.00 | 105,000.00 | 155,000.00 | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019587/0001493152-20-019587-index.htm |
2020-10-16 | Opaleye Management Inc. | 10% Share Holder | Buy | 385,000.00 | 7.00 | 2,695,000.00 | 3,885,000.00 | https://www.sec.gov/Archives/edgar/data/1710340/000149315220019587/0001493152-20-019587-index.htm |
2018-11-15 | William Wilson Troutman | CFO, Treasurer & Secretary | Buy | 5,000.00 | 6.00 | 30,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058822/0001209191-18-058822-index.htm |
2018-11-15 | NORBERT G RIEDEL | Director | Buy | 5,000.00 | 6.00 | 30,000.00 | 59,745.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058824/0001209191-18-058824-index.htm |
2018-11-15 | PAUL V MAIER | Director | Buy | 5,000.00 | 6.00 | 30,000.00 | 59,745.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058825/0001209191-18-058825-index.htm |
2018-11-15 | CHARLES J CASAMENTO | Director | Buy | 5,000.00 | 6.00 | 30,000.00 | 68,420.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919118058827/0001209191-18-058827-index.htm |
2019-08-09 | CHARLES J CASAMENTO | Director | Buy | 3,500.00 | 6.11 | 21,369.95 | 71,920.00 | https://www.sec.gov/Archives/edgar/data/1710340/000120919119045498/0001209191-19-045498-index.htm |